Evidence map›Paper›PMID 39769108›Full record

ArticleInternational journal of molecular sciences2024

Ticagrelor Induces Angiogenesis in Progenitor and Mature Endothelial Cells In Vitro: Investigation of the Possible Role of Adenosine.

Sofia Sidiropoulou, Aikaterini Gatsiou, Kenny M Hansson, Aikaterini N Tsouka, Konstantinos Stellos, Alexandros D Tselepis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sofia SidiropoulouAtherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 451 10 Ioannina, Greece.ORCID 0000-0001-8077-7087
Aikaterini GatsiouCardiovascular Disease Prevention Hub, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.ORCID 0000-0003-4144-4305
Kenny M HanssonBioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Aikaterini N TsoukaAtherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 451 10 Ioannina, Greece.ORCID 0000-0002-3287-1367
Konstantinos StellosCardiovascular Disease Prevention Hub, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
Alexandros D TselepisAtherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 451 10 Ioannina, Greece.ORCID 0000-0002-5854-2385

Funding

Astrazeneca, Sweden 81691
6 · The paper itself

Abstract

Ticagrelor, a reversible platelet P2Y

Indexed as

AdenosineNeovascularization, PhysiologicTicagrelorAngiogenesisCells, CulturedEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsAdenosineTicagreloradenosineangiogenesisendothelial colony-forming cellsendothelial progenitor cellsequilibrative nucleoside transporter-1ticagrelor

Identifiers

PMID39769108
PMCPMC11727715

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.